Continuous glucose monitoring for HIE newborns
Part of Hormones & metabolism clinical trials.
This study tests a continuous glucose monitor (CGM) in newborns with hypoxic-ischemic encephalopathy (HIE) — a type of brain injury from lack of oxygen around birth. The CGM tracks sugar levels to help doctors manage care better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born at 35 weeks or later
- Birth weight over 1.8 kg (about 4 pounds)
- Age under 6 hours now
- Diagnosed with moderate or severe HIE due to lack of oxygen at birth
- No major birth defects, metabolic disorders, or serious infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a continuous glucose monitor (a small patch that tracks your blood sugar) for a few weeks after you give birth. It aims to see if this tool can help women who recently had gestational diabetes better understand their blood sugar levels after delivery.
This study tests whether a small continuous glucose monitor (a sensor that checks your sugar levels all the time) can be used easily in youth who are in the hospital. It may help doctors track your blood sugar closely without needing as many finger sticks.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This study uses a small sensor to continuously monitor blood sugar levels in newborns whose mothers had insulin-treated gestational diabetes. It aims to make sure babies' glucose levels stay healthy after birth.
This study checks whether a small sensor that measures blood sugar continuously is accurate in newborn babies. It may help doctors better monitor and care for babies' sugar levels after birth.
This study will look at how well Dexcom continuous glucose monitors (CGMs) work in real life. It helps people with diabetes track their blood sugar levels and may lead to better control of their condition.
Hear when a new Hypoxic Ischemic Encephalopathy of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.